Mina publikationer

Artiklar.

1. Torffvit O, Wieslander J. A simplified enzyme-linked immunosorbent assay for urinary albumin. Scand J Clin Lab Invest 1986; 46: 545-8.

2. Torffvit O, Persson G. Is exercise-induced blood pressure rise predictive of nephropathy in insulin-dependent diabetes? Acta Med Scand 1987; 221: 299-302.

3. Torffvit O, Castenfors J, Bengtsson U, Agardh C-D. Exercise stimulation in insulin-dependent diabetics, normal increase in albuminuria with abnormal blood pressure response. Scand J Clin Lab Invest 1987; 47: 253-9.

4. Torffvit O, Agardh C-D, Cederholm B, Wieslander J. A new enzyme-linked immunosorbent assay for urine and serum concentrations of the carboxyterminal domain (NC1) of collagen IV. Application in Type I (insulin-dependent) diabetes? Scand J Clin Lab Invest 1989; 49: 431-9.

5. Agardh E, Torffvit O, Agardh C-D. The prevalence of retinopathy and associated medical risk factors in Type I (insulin-dependent) diabetes mellitus. J Int Med 1989; 226: 47-52.

6. Agardh E, Torffvit O, Agardh C-D. Putative risk factors associated with retinopathy in patients with diabetes diagnosed at or after 30 years of age. Diabetic Medicine 1989; 6: 724-7.

7. Torffvit O, Wieslander J, Forsberg L, Hederström E, Agardh C-D. Urinary excretion of the carboxyterminal domain (NC1) of collagen IV is associated with kidney size and glomerular filtration rate in Type I (insulin-dependent) diabetes mellitus. J Diab Comp 1990; 4(4):166-169.

8.  Torffvit O, Castenfors J, Agardh C-D. A study of exercise induced microalbuminuria in Type I (insulin-dependent) diabetes mellitus. Scan J Urol Nephrol 1991; 25: 39-43.

9. Torffvit O, Agardh E, Agardh C-D. Albuminuria and associated medical risk factors. A cross-sectional study in 476 Type I (insulin-dependent) diabetic patients. Part 1. J Diab Comp 1991; 5(1): 23-28.

10. Torffvit O, Agardh E, Agardh C-D. Albuminuria and associated medical risk factors. A cross-sectional study in 451 Type II (non-insulin-dependent) diabetic patients. Part 2. J Diab Comp 1991; 5(1): 28-34.

11. Torffvit O, Agardh C-D, Alm P, Wieslander J. Urine and serum levels of the carboxyterminal domain (NC1) of collagen IV in membranous glomerulonephritis and diabetic nephropathy. Nephron 1991; 59: 15-20.

12. Torffvit O, Agardh C-D, Kjellsson B, Wieslander J. Tubular secretion of Tamm-Horsfall protein in Type 1 (insulin-dependent) diabetes mellitus using a simplified enzyme linked immunoassay. Clin Chim Acta 1992; 205: 31-41.

13. Torffvit O, Agardh C-D. Day and night variation in ambulatory blood pressure in type 1 diabetes mellitus with nephropathy and autonomic neuropathy. J Int Med  1993, 233: 131-137.

14. Torffvit O, Agardh C-D. Tubular secretion of Tamm-Horsfall protein is decreased in type 1 (insulin-dependent) diabetic patients with diabetic nephropathy. Nephron 1993, 65: 227-231.

15.  Torffvit O, Agardh C-D. The predictive value of albuminuria for cardiovascular and renal disease. A 5-year follow-up study of 476 patients with type I diabetes mellitus. J Diab Comp 1993, 7 (1): 49-56.

16. Torffvit O, Agardh C-D.  Urinary excretion of NC1 and Tamm-Horsfall protein in the microalbuminuric type I diabetic patient. J Diab Comp 1994; 8(2): 77-83.

17. Agardh E, Agardh C-D, Koul S, Torffvit O. A four year follow-up study on the incidence of diabetic retinopathy in older onset diabetes mellitus. Diabetic Medicine 1994; 11: 273-278.

18. Agardh E, Agardh C-D, Torffvit O. A five-year follow-up study on the incidence of retinopathy in type 1 diabetes mellitus in relation to medical risk factors. J Int Med 1994; 235: 353-358.

19. Torffvit O, Thysell H, Nässberger L. Occurrence of autoantibodies directed against myeloperoxidase and elastase in patients treated with hydralazine and presenting with glomerulonephritis. Human & Exp Toxicology 1994; 13: 563-567.

20. Torffvit O, Agardh E, Agardh C-D. The association  between blood pressure and progression of diabetic nephropathy in antihypertensive-treated type 1 diabetic patients. Diabetic Research 1994, 27: 91-103.

21. Rasch R, Torffvit O, Bachman S, Jensen PK, Jacobsen NO. Tamm-Horsfall glycoprotein in streptozotocin diabetic rats: A study of kidney in situ hybridization, immunohistochemistry and urinary excretion. Diabetologia 1995; 38: 525-535.

22. Torffvit O. Is human insulin without effect in the diabetic rat? Diabetologia 1995; 38: 1492.

23. Catalano C, Torffvit O. Urinary excretion of Tamm-Horsfall protein in normotensive, normo-albuminuric type 1 diabetic patients. Nephron 1996; 72: 436-441.

24. Apelqvist J, Torffvit O, Agardh C-D. The effect of the non-ionic contrast medium iohexol on glomerular and tubular function in diabetic patients. Diabetic Med, 1996, 13: 487-492.

25. Agardh C-D, Agardh E, Torffvit O. The prognostic value of albuminuria for the development of cardiovascular disease and retinopathy: a 5-year follow-up study of 451 patients with type 2 diabetes mellitus. Diab Res Clin Pract, 1996, 32: 35-44.

26. Lindqvist A, Torffvit O, Rittner R, Agardh C-D, Pahlm O. Artery blood pressure oscillation after active standing up: an indicator of sympathetic function in diabetic patients. Clinical Physiol 1997, 17: 159-169.

27. Torffvit O, Adamsson M, Edvinsson L. Renal arterial activity to potassium, noradrenaline and neuropeptide Y and association with urinary albumin excretion in the diabetic rat. J Diabet Complications, 1997;11: 279-286.

28. Torffvit O, Lindqvist A, Agardh C-D, Pahlm O. The association between diabetic nephropathy and autonomic nerve function in type 1 diabetic patients. Scan J Clin Lab Invest 1997; 57: 183-192.

29. Tencer J, Torffvit O, Thysell H, Grubb A, Rippe B. Decreased excretion of urine glycosaminoglycans as marker in renal amyloidosis.  Nephrol Dial Transpl  1997; 12: 1161-1166.

30. Agardh C-D, Agardh E, Torffvit O. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5-year follow-up study of 442 adult patients in routine care. Diab Res Clin Pract 1997; 35: 113-121.

31. Torffvit O, Agardh C-D, Mattiasson A. Lack of association between cystopathy and progression of diabetic nephropathy in insulin-dependent diabetes mellitus. Scan J Urol Nephrol 1997; 31: 365-369.

32. Torffvit O, Kamper A-L, Strandgaard S. Tamm-Horsfall protein in urine after uninephrectomy/transplantation in kidney donors and their recipients. Scan J Urol Nephrol 1997; 31: 555-559.

33. Torffvit O, Edvinsson L. Blockade of nitric oxide decreases the renal vasodilatory effect of neuropeptide Y in the insulin-treated diabetic rat. Pflüg Archiv-Eur J Physiol 1997, 434: 445-450.

34. Tencer J, Torffvit O, Thysell H, Grubb A, Rippe B. Decreased excretion of glycosaminoglycans in patients with primary glomerular disease. Clin Nephrol 1997, 48: 212-219.

35. Catalano C, Muscelli E, Galvan AQ, Baldi S, Masoni A, Gibb I, Torffvit O, Seghieri G, Ferrannini E. Effect of insulin on systemic and renal handling of albumin in nondiabetic and NIDDM subjects. Diabetes 1997, 46(5): 868-75.

36. Thulesen J, JørgensenPE, Torffvit O, Nexø E, Poulsen SS. Urinary excretion of epidermal growth factor (EGF) and Tamm-Horsfall protein (THP) in three rat models with increased renal work load. 1997, Reg Peptides, 1997; 72: 179-186.

37. Torffvit O, Jørgensen PE, Kamper A-L, Holstein-Rathlou N-H, Leyssac PP, Poulsen SS, Strandgaard S. Urinary excretion of Tamm-Horsfall protein and epidermal growth factor in chronic nephropathy. Nephron 1998; 79:167-172.

38. Tencer J, Torffvit O, Thysell H, Rippe B, Grubb A. Proteinuria selectivity index based upon 2-macroglobulin or IgM is superior to the IgG based index in differentiating glomerular diseases. Technical note. Kidney Int 1998, 54 (6): 2098-105.

39. Torffvit O, Edvinsson L. Relaxing effect of insulin in renal arteries from diabetic rats. Reg Peptides 1999; 79: 147-152.

40. Torffvit O, Agardh C-D, Thulin T. A study of Tamm-Horsfall protein excretion in hypertensive patients and type 1 diabetic patients. Scan J Urol Nephrol 1999; 33: 187-191.

41. Torffvit O. Urinary sulphated glycosaminoglycans and Tamm-Horsfall protein in type 1 diabetic patients. Scan J Urol Nephrol 1999; 33: 328-332.

42. Tencer J, Torffvit O, Thysell H, Rippe B, Grubb A. Urine IgG2/IgG4-ratio indicates the significance of the charge selective properties of the glomerular capillary wall for the macromolecular transport in glomerular diseases. Nephrol Dial Transplant 1999; 14: 1425-1429.

43. Torffvit O, Rippe B. Size and charge selectivity of the glomerular filter in patients with insulin-dependent diabetes mellitus. Urinary immunoglobulins and glycosaminoglycans. Nephron 1999; 83:301-307.

44. Tencer J, Bakoush O, Torffvit O. Diagnostic and prognostic significance of proteinuria selectivity index in glomerular disease. Clin Chim Acta 2000; 297 (1-2): 73-83.

45. Thorup C, Ollerstam A, Persson AEG, Torffvit O. Increased tubuloglomerular feedback activity is associated with increased NO production in the streptozotocin-diabetic rat. J Diab Compl 2000; 14: 46-52

46. Torffvit O, Agardh C-D. The prognosis for type 2 diabetic patients with heart disease. A 10-year observation study of 385 patients. J Diab Compl 2000; 14: 301-306.

47. Torffvit O, Agardh C-D. Treatment mode and development of diabetic complications. A 10-year observation study of 385 type 2 diabetic patients. Diabetes Research 2000, 35: 117-125.

48. Holmquist P, Torffvit O, Jörgensen PE, Tørring N, Nexö E, Sjöblad S. Early urinary changes in Tamm-Horsfall protein and epidermal growth factor in diabetic children. Pediatric Nephrology 2001; 16: 488-492.

49. Bakoush O, Torffvit O, Rippe B, Tencer J. High proteinuria selectivity index based upon IgM is a strong predictor of  poor renal survival in glomerular diseases. Nephrol Dial Transp 2001; 16: 1357-1363.

50. Torffvit O, Agardh C-D. The impact of metabolic and blood pressure control on incidence and progression of nephropathy. A 10-years study of 385 type 2 diabetic patients. J Diab Compl 2001; 15: 307-313.

51. Lövestam-Adrian M, Agardh C-D, Torffvit O, Agardh E. Diabetic retinopathy, visual acuity and medical risk indicators. A continuous 10-year follow-up study in type 1 diabetic patients under routine care. J Diab Compl 2001; 15: 287-294.

52. østerby R, Tapia J, Nyberg G, Tencer J, Willner J, Rippe B, Torffvit O. Renal structure in type 2 diabetic patients with elevated albumin excretion rate. Acta Pathologica, Microbiologica et Immunologica, Scandinavica (APMIS) 2001; 109: 751-761.

53. Torffvit O, Agardh C-D. Systolic blood pressure but not metabolic control is associated with stroke in type 2 diabetes during a 10 year observation period. Diabetes Research 2001, 36: 029-036.

54 Bakoush O, Tencer J, Tapia Juan, Rippe B, Torffvit O. Higher urinary IgM excretion in type 2 diabetic nephropathy compared to type 1 diabetic nephropathy. Kidney Int 2002; 61: 203-208.

55. Torffvit O, Agardh C-D. A blood pressure cut-off level identified for renal failure, but not for macrovascular complications in type 2 diabetic patients: A 10-year observational study. Hormone Metabolic Research 2002; 34: 32-35.

56. H. Strevens, D. Wide-Swensson, O. Torffvit, A. Grubb. Serum cystatin C for assessment of glomerular filtration rate in pregnant and non-pregnant women. Indications of altered filtration process in pregnancy. Scand J Clin Lab Invest 2002; 62(2):141-7.

57. Agardh C-D, Stenram U, Torffvit O, Israelsson B, Thuesen B, Agardh E. Effects of inhibition of glycation and oxidative stress on the development of diabetic nephropathy in rats.  J Diab Compl 2002; 16(6): 395-400.

58. Ulf Ekelund, Hans-Jörgen Nilsson, Attila Frigyesi, Ole Torffvit. Patients with suspected acute coronary syndrome in a university hospital emergency department: an observational study. BMC Emergency Medicine 2002, 2:1: 1-7. http://www.biomedcentral.com/1471-227X/2/1.

59. Bakoush O, Torffvit O, Rippe B, Tencer J. Renal function in proteinuric glomerular diseases correlates to the changes in urine IgM excretion but not to the changes in the degree of albuminuria. Clin Nephrol 2003; 59: 345-352.

60. Holmquist P, Torffvit O, Sjöblad S. The effect of acute metabolic control on renal function at onset of diabetes in children. Pediatric Nephrology 2003, 18: 536-540.

61. Lövenstam-Adrian M, Agardh C-D, Torffvit O, Agardh E. Type 1 diabetes patients with severe non-proliferative retinopathy may benefit from panretinal photocoagulation. Acta Ophthalmologica Scand 2003; 81: 221 – 225.

62. Strevens H, Wide-Swensson D, Grubb A, Hansen A, Horn T, Ingemarsson I, Larsen S, Nyengaard JR, Torffvit O, Willner J, Olsen S. Serum cystatin C reflects glomerular endotheliosis in normal, hypertensive and pre-eclamptic pregnancies. BJOG 2003, 110: 825-830.

63. Rabiyana Dash, Ole Torffvit. How to predict diabetic nephropathy by exercise testing. Routine data or provocation by exercise testing. Scan J  Urol Nephrol 2003; 37: 437-442.

64. Kalani M, Apelqvist J, Blombäck M, Brismar K, Eliasson B, Eriksson JW, Fagrell B, Hamsten A, Torffvit O, Jörneskog G. Effect of dalteparin on healing of chronic foot ulcers in diabetic patients with peripheral arterial occlusive disease: a prospective, randomised, double-blind and placebo-controlled study. Diabetes Care 2003; 26: 2575-2580.

65. Svensson M, Sundkvist G, Arnqvist HJ, Björk E, Blohmé G, Bolinder J, Henricsson M, Nyström L, Torffvit O, Waernbaum I, Östman J, Eriksson JW. Signs of nephropathy may occur early in young adults with diabetes despite modern diabetes management. Results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care 2003; 26: 2903-2909.

66. Torffvit O, Melander O, Hultén UL. Urinary excretion rate of Tamm-Horsfall protein is related to salt intake in man. Nephron-Physiology 2004; 97(1): 31-36.

67. Bakoush O, Tencer J, Torffvit O, Tenstad O, Skogvall I, Rippe B. Increased glomerular albumin permeability in old spontaneously hypertensive rats. Nephrol Dial Transplant 2004; 19(7):1724-31.

68. Torffvit O, Tapia J, Rippe B, Alm P, Willner J, Tencer J. Ambulatory blood pressure in type 2 diabetic patients with albuminuria: Relation to renal function and structural lesions. J Diabetes Compl 2004; 18: 328-335.

69. Holmquist P, Sjöblad S, Ole Torffvit O. Size and charge selectivity of the glomerular basal membrane at diagnosis of diabetes in children. Pediatric Nephrology 2004, 19(12): 1361-6.

70. Torffvit O, Löwenstam-Adrian M, Elisabeth Agardh, Carl-David Agardh C-D. Nephropathy, but not retinopathy, is associated with the development of heart disease in type 1 diabetes: a 12-year observation study of 462 patients. Diabetic Med 2005; 22: 723-729.

71. Kurkus J, Schön S, Prütz K-G, Torffvit O. Allt fler njursjuka diabetiker i dialys. Bättre diabeteskontroll och blodtrycksbehandling kan motverka trenden. Läkartidningen 2005; 255 (18-19): 1420-1423.

72. Kurkus J, Schön S, Prütz K-G, Torffvit O. Allt fler njursjuka diabetiker i dialys. Bättre diabeteskontroll och blodtrycksbehandling kan motverka trenden. DiabetologNytt  2005; 18 (3): 243-245.

73. Ulf Ekelund, Hans-Jörgen Nilsson, Ole Torffvit, Jakob Lundager Hansen. Effektiviserad utredning möjlig vid misstänkt akut koronart syndrom. Läkartidningen 2005; 102(7): 464-466.

74. Bakoush O, Segelmark M, Torffvit O, Ohlsson S, Tencer J. Urine IgM excretion predicts outcome in ANCA-associated renal vasculitis. Nephrol Dial Transplant 2006; 21(5):1263-9.

75. M Lövestam-Adrian, C Hansson-Lundblad, O Torffvit. Sight-threatening retinopathy is associated with lower mortality in Type 2 diabetic subjects: A 10-year observation study. Diabetes Research and Clinical Practice 2007; 77: 141-147.

76. Ole Torffvit, Jan W. Eriksson, Marianne Henricsson, Göran Sundqvist, Hans J. Arnqvist, Göran Blohmé, Jan Bolinder, Lennarth Nyström, Jan Östman, Maria Svensson. Early changes in glomerular size selectivity in young adults with type 1 diabetes and retinopathy. Results from the Diabetes Incidence Study in Sweden. J Diabetes Compl 2007; 21: 246-251.

77. Majid Kalani, Angela Silveira, Margareta Blombäck , Jan Apelqvist, Björn Eliasson, Jan W Eriksson, Bengt Fagrell, Ole Torffvit, Anders Hamsten, Gun Jörneskog. Beneficial effects of dalteparin on haemostatic function and local tissue oxygenation in patients with diabetes, severe vascular disease and foot ulcers. Thrombosis Research. 2007; 120(5):653-61.

78. Catarina Rippe, Anna Rippe, Ole Torffvit, Bengt Rippe. Size and charge selectivity of the glomerular filter in early experimental diabetes mellitus in rats. Am J Physiol Renal Physiol 2007; 293(5):F1533-8.

79. Sejdiu I, Torffvit O. Decreased urinary concentration of Tamm-Horsfall protein is associated with development of renal failure and cardiovascular death within 20 years in type 1 but not in type 2 diabetic patients. Scan J Urol Nephrol 2008; 42(2):168-74.

80. Peter Holmquist, Ole Torffvit. Tubular function in diabetic children assessed by Tamm-Horsfall protein and glutathione S-transferase. Pediatric Nephrology 2008;23(7):1079-83.

81. Peter Holmquist, Ole Torffvit. Urinary transforming growth factor-beta (1), Collagen IV and the effect of insulin in children at diagnosis of diabetes mellitus.  Scan J Urol Nephrol 2009; 43(2):142-147

82 Ohlsson S, Bakoush O, Tencer J, Torffvit O, Segelmark M. Monocyte chemoattractant protein 1 is a prognostic marker in ANCA-associated small vessel vasculitis. Mediators of Inflammation 2009; Article id 584916, doi:10.1155/2009/584916. http://www.hindawi.com/journals/mi/2009/584916.html

83.Tofik R, Torffvit O, Rippe B, Bakoush O. Increased urine IgM excretion predicts cardiovascular events in patients with type 1 diabetes nephropathy. BMC Medicine2009, 7:39. Article id doi:10.1186/1741-7015-7-39.  http://www.biomedcentral.com/1741-7015/7/39.

84. Torffvit O. Effect of epoietininduced normal Hb on progression of nephropathy in insulin treated diabetic patients with renal anaemia. Int J Nephrol Urol 2009; 1(2): 113-123.

85. Torffvit O, Tencer J, Rippe B. The response to antihypertensive therapy is dependent on renal structural changes. A five year prospective study of renal biopsy in type 2 diabetic patients with micro-macroalbuminuria. J Diabetes Compl 2010; 24: 361-367.

86. Jendle Johan, Torffvit Ole, Ridderstråle Martin, Lammert Morten, Ericsson Åsa, Bøgelund Mette. Willingness to pay for health improvements associated with antidiabetic treatments for people with type 2 diabetes. Current Medical Research & Opinion 2010; 26 (4):917-23. [Epub ahead of print] 17 February 2010; doi:10.1185/03007991003657867  

87. Möllsten A, Torffvit O. Tamm-Horsfall protein gene and retinopathy are associated with tubular dysfunction in type 1 diabetic patients. Scan J Urol Nephrol  2010, 44: 438-444.

88. Sandosh Padmanabhan, Olle Melander,Toby Johnson,Anna Maria Di Blasio, Wai K Lee, Davide Gentilini, Claire E. Hastie, Cristina Menni, Maria Cristina Monti, Christian Delles, Stewart Laing, Barbara Corso, Gerjan Navis, Arjan Kwakernaak, Pim van der Harst, Murielle Bochud, Marc Maillard, Michel Burnier, Thomas Hedner, Sverre Kjeldsen, Björn Wahlstrand, Marketa Sjögren, Cristiano Fava, Martina Montagnana, Elisa Danese, Ole Torffvit, Bo Hedblad, Harold Snieder, John M.C. Connell, Morris Brown, Nilesh J. Samani, Martin Farrall, Giancarlo Cesana, Giuseppe Mancia, Stefano Signorini, Guido Grassi, Susana Eyheramendy, H. Erich Wichmann, Maris Laan, David P Strachan, Peter Sever, Denis Shields, Alice Stanton, Peter Vollenweider, Alexander Teumer, Henry Völzke, Rainer Rettig, Christopher Newton-Cheh, Pankaj Arora, Feng Zhang, Nicole Soranzo, Tim Spector, Gavin Lucas, Sekar Kathiresan, David Siscovick, Jian'an Luan, Ruth J.F. Loos, Nicholas J. Wareham, Brenda W. Penninx, Ilja M. Nolte, Martin McBride, William H. Miller, Stuart A Nicklin, Andrew H Baker, Delyth Graham, Robert A McDonald, Jill Pell, Naveed Sattar, Paul Welsh, Patricia  B. Munroe, Mark Caulfield, Alberto Zanchetti, Anna F Dominiczak . Genomewide association study of blood pressure extremes identifies variant in UMOD associated with hypertension. PLoS Genetics 2010; 6 (10)e1001177.doi:10.1371/journal.pgen.1001177

89. Tofik R, Torffvit O, Rippe B, Bakoush O. Urine IgM-excretion as a prognostic marker for progression of type 2 diabetic nephropathy. Diabetes Research and Clinical Practice 2012 Jan;95(1):139-44. Epub 2011 Nov 10.

90. Lind M, Jendle J, Torffvit O, Lager I. Glucagon-like peptide 1 (GLP-1) analogue combined with insulin reduces HbA1c and weight with low risk of hypoglycemia and high treatment satisfaction. Primary Care Diabetes 2011, Oct 17. [Epub ahead of print]. 2012;6:41-46.

 91. Jendle J, Ridderstråle M, Torffvit O, Ericsson Å, Larsen S. Willingness-to-pay for benefits associated with basal insulin treatment of type 2 diabetes. J Medical Economics 2012;15(2): 1-3.

92. Torffvit O, Kalani M, Apelqvist J, Eliasson B, Eriksson J, Brismar K, Jörneskog G. Increased urine IgM and IgG2 levels, indicating decreased glomerular size selectivity, are not affected by dalteparin therapy in patients with type 2 diabetes. Biochemistry Research International. Special issue Glycosaminoglycans metabolism, Doi:10.1155/2012/480529.

93.  Torffvit O. The effect of achieving a systolic blood pressure of 140 mmHg. Ambulatory measurements in type 2 diabetic patients with nephropathy. J Diabetes Complications 2012, jul 4 [epub ahead of print]. 26(6):540-5.

94.  Jendle Johan, Torffvit Ole, Ridderstråle Martin, Ericsson Åsa, Nilsen Björn, Bøgelund Mette. Willingness to pay for diabetes drug therapy in type 2 diabetes patients: based on LEAD clinical programme results. J Med Econ. 2012, Aug 1 [epub ahead of print]. 15 Suppl 2:1-5.

95. Rafid Tofik¹², Ulf Ekelund¹², Ole Torffvit², Per Swärd,2 Bengt Rippe², Omran Bakoush². Increased Urinary IgMExcretion in Patients with Chest Pain Due to Coronary Artery Disease.BMC Cardiovascular Disorders 2013; 13: 72, doi: 10.1186/1471-2261-13-72.

96. Marcus Lind, Irl B Hirsch, Jaakko Tuomilehto, Sofia Dahlqvist, Ole Torffvit, Nils-Gunnar Pehrsson. Design and Methods of a randomized double-blind trial of adding liraglutide to control HbA1c in patients with type 2 diabetes with impaired glycaemic control treated with multiple daily insulin injections (MDI-Liraglutide trial). Primary Care Diabetes 2015; 9: 15-22. [e-pub ahead of print 28 aug 2014]

97. Rafid Tofik, Per Swärd, Ulf Ekelund, André Struglics, Ole Torffvit, Bengt Rippe, Omran Bakoush. Plasma pro-inflammatory cytokines, IgM-uria and cardiovascular events in patients with chest pain: A comparative study. Scan J Clin Lab Invest 2015, jul 15: 1-8,  [e-pub ahead of print ]

98. Lind M, Hirsch IB, Tuomilehto J, Dahlqvist S, Ahrén B, Torffvit O, Attvall S, Ekelund M, Filipsson K, Tengmark B-O, Sjöberg S, Pehrsson N-G. Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial). BMJ 2015; 351: h5364 doi:10.1136/bmj.h5364

99. Wijkman MO, Dena M, Dahlqvist S, Sofizadeh S, Hirsch I, Tuomilehto J, Mårtensson J, Torffvit O, Imberg H, Saeed A, Lind M. Predictors and correlates of systolic blood pressure reduction with liraglutide treatment in patients with type 2 diabetes. J Clin Hypertension 2018; 1-11, doi10.1111/jch.13447

100. Mistry HD, Kurlak LO, Gardner DS, Torffvit O, Hansen A, Broughton P, Strevens H. Evidence of augmented intrarenal angiotensinogen associated with glomerular swelling in gestational hypertension and preeclampsia: Clinical implications. Am Heart Assoc 2019; 8:e 12611. DOI: 10.1161/JAHA. 119.012611.

101. Swärd P, Tofik R, Bakoush O, Torffvit O, Nilsson PM, Christensson A. Patterns of urinary albumin and IgM associate with markers of vascular ageing in young to middle-aged individuals in the Malmö offspring study. BMC. Cardiovascular Disorders 2020; 20: 358. https://doi.org/10.1186/s12872-020-01638-3